Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Passage Bio Inc
(NQ:
PASG
)
0.8380
+0.0180 (+2.20%)
Streaming Delayed Price
Updated: 10:50 AM EDT, Aug 27, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Passage Bio Inc
< Previous
1
2
3
4
5
Next >
PASG Stock Earnings: Passage Bio Beats EPS for Q2 2024
August 08, 2024
PASG stock results show that Passage Bio beat analyst estimates for earnings per share the second quarter of 2024.
Via
InvestorPlace
Passage Bio Reports Second Quarter 2024 Financial Results and Provides Recent Business Highlights
August 08, 2024
From
Passage Bio
Via
GlobeNewswire
Passage Bio to Participate in Upcoming Investor Conferences
August 06, 2024
From
Passage Bio
Via
GlobeNewswire
Passage Bio Out-licenses Three Pediatric Gene Therapy Programs to GEMMA Biotherapeutics and Enters New Research Collaboration
August 01, 2024
From
Passage Bio
Via
GlobeNewswire
Recap: Passage Bio Q3 Earnings
November 13, 2023
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
July 16, 2024
It's time to dive into the biggest pre-market stock movers as we check out all of the latest news worth reading about on Tuesday morning!
Via
InvestorPlace
Passage Bio Announces Positive Feedback from FDA on Expansion of upliFT-D Trial of PBFT02 to Include FTD-C9orf72 Patients
July 16, 2024
From
Passage Bio
Via
GlobeNewswire
Passage Bio to Present at Goldman Sachs 45th Annual Global Healthcare Conference
June 05, 2024
From
Passage Bio
Via
GlobeNewswire
PASG Stock Earnings: Passage Bio Beats EPS for Q1 2024
May 14, 2024
PASG stock results show that Passage Bio beat analyst estimates for earnings per share the first quarter of 2024.
Via
InvestorPlace
Passage Bio Reports First Quarter 2024 Financial Results and Provides Recent Business Highlights
May 14, 2024
From
Passage Bio
Via
GlobeNewswire
Passage Bio to Present at Chardan’s 8th Annual Genetic Medicines and Cell Therapy Manufacturing Summit
April 22, 2024
From
Passage Bio
Via
GlobeNewswire
PASG Stock Earnings: Passage Bio Beats EPS for Q4 2023
March 06, 2024
PASG stock results show that Passage Bio beat analyst estimates for earnings per share the fourth quarter of 2023.
Via
InvestorPlace
Passage Bio Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Recent Business Highlights
March 04, 2024
From
Passage Bio
Via
GlobeNewswire
Passage Bio to Participate in Upcoming Investor Conferences
February 27, 2024
From
Passage Bio
Via
GlobeNewswire
7 Analyst-Backed Stocks With Promising 10-Bagger Potential
February 01, 2024
Although true 10-baggers are by nature extremely difficult to come by, these analyst-backed stocks may offer a decent shot.
Via
InvestorPlace
Passage Bio to Present at Guggenheim Healthcare Talks 6th Annual Biotechnology Conference
January 31, 2024
From
Passage Bio
Via
GlobeNewswire
12 Health Care Stocks Moving In Friday's Pre-Market Session
January 26, 2024
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
January 22, 2024
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
January 17, 2024
Via
Benzinga
7 Nano-Cap Stocks That Pack a Serious Punch for Their Weight
December 25, 2023
Although nano-cap stocks are super-risky just like stealing bases in baseball, there may be a time and place for extreme speculation.
Via
InvestorPlace
12 Health Care Stocks Moving In Thursday's Pre-Market Session
December 21, 2023
Via
Benzinga
Why BlackBerry Shares Are Trading Lower By Over 5%; Here Are 20 Stocks Moving Premarket
December 21, 2023
Shares of BlackBerry Limited (NYSE: BB) moved lower in pre-market trading following the release of third-quarter results.
Via
Benzinga
Neurology-Focused Passage Bio Reveals Initial Data From Dementia Study, Outlines Strategic Priorities
December 20, 2023
Passage Bio Inc (NASDAQ: PASG) announced initial safety and biomarker data from three Cohort 1 patients in the ongoing global Phase 1/2 upliFT-D clinical trial evaluating PBFT02, an adeno-associated...
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
December 20, 2023
Via
Benzinga
Passage Bio Announces Promising Initial Data From Phase 1/2 Clinical Trial of PBFT02 in FTD-GRN and Updated Strategic Priorities
December 20, 2023
From
Passage Bio
Via
GlobeNewswire
Passage Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)
November 17, 2023
From
Passage Bio
Via
GlobeNewswire
Monday.Com To Rally Around 20%? Here Are 10 Top Analyst Forecasts For Tuesday
November 14, 2023
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page
Via
Benzinga
Passage Bio Reports Third Quarter 2023 Financial Results and Provides Recent Business Highlights
November 13, 2023
From
Passage Bio
Via
GlobeNewswire
12 Health Care Stocks Moving In Friday's After-Market Session
November 03, 2023
Via
Benzinga
Passage Bio to Present at Guggenheim’s 5th Annual Inflammation, Neurology & Immunology Conference
October 30, 2023
From
Passage Bio
Via
GlobeNewswire
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.